Pandemic Oversight - Home
The Pandemic Response Accountability Committee (PRAC) was established by the CARES Act in 2020 to ensure comprehensive oversight of pandemic funding and promote transparency …
About Us | Pandemic Oversight
We are the Pandemic Response Accountability Committee (PRAC) providing data-driven oversight of pandemic relief funds and programs funded by Public Law 119-21, commonly …
The Pandemic Response Accountability Committee (PRAC) oversees and ensures transparency in the spending of over $5 trillion across 500 pandemic relief programs.
Log in to your EHR account and start charting | Practice Fusion
Log in to your Practice Fusion EHR account with valid email and password. Practice Fusion is the #1 cloud-based electronic health record (EHR) platform for doctors and patients in the U.S.
Pandemic Response Accountability Committee - Oversight.gov
Oct 1, 2024 · The report summarizes the PRAC’s work during the first half of Fiscal Year 2024 and updates Congress on our efforts to promote transparency and ensure coordinated …
Pandemic Response Accountability Committee - Wikipedia
The Pandemic Response Accountability Committee (PRAC) is an independent oversight committee within the Council of the Inspectors General on Integrity and Efficiency, created by …
Newsroom - Pandemic Oversight
Washington, DC — Today, Michael E. Horowitz, Chair of the Pandemic Response Accountability Committee (PRAC), announced the release of the PRAC’s Semiannual Report to Congress, …
Meet Our Executive Director - Pandemic Oversight
He brings over 28 years of experience in the oversight community and has served in various roles related to investigations and data analytics with the U.S. Air Force, the Department of Justice, …
What is the PRAC? The Pandemic Response Accountability Committee (PRAC) oversees pandemic relief spending and coordinates oversight among our member Inspectors General.
Pharmacovigilance Risk Assessment Committee (PRAC)
Jan 20, 2025 · PRAC was formally established in line with the pharmacovigilance legislation which came into effect in 2012 to help strengthen the safety monitoring of medicines across Europe.